Sofwave Earns Frost & Sullivan's 2023 North American Technology Innovation Leadership Award for Developing a Sophisticated Skin Tightening Ultrasound Technology with Minimal Downtime

Frost & Sullivan Sofwave Medical Ltd. Texas California

(TASE: SOFW) has implemented an innovative approach to wrinkle reduction lifting and cellulite using its proprietary breakthrough technology. SUPERB™, Synchronous Ultrasound Parallel Beam technology is FDA-cleared to improve facial lines and wrinkles, lifting the eyebrow and lifting lax submental tissue (beneath the chin) and neck tissue, the short-term improvement in the appearance of cellulite and treatment of acne scars, providing physicians with smart yet simple, effective, and safe aesthetic solutions for their patients.

Contact: [e-mail]

Investor Contact:
Brian Ritchie
LifeSci Advisors LLC
[phone]
[e-mail]

Logo - https://mma.prnewswire.com/media/2280561/Frost_and_Sullivan_Sofwave_Award_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/sofwave-earns-frost--sullivans-2023-north-american-technology-innovation-leadership-award-for-developing-a-sophisticated-skin-tightening-ultrasound-technology-with-minimal-downtime-301992673.html